Gilead Sciences, Inc [GILD] stock prices are up 0.57% to $111.79 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GILD shares have gain 4.40% over the last week, with a monthly amount drifted -0.18%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gilead Sciences, Inc [NASDAQ: GILD] stock has seen the most recent analyst activity on March 04, 2025, when Oppenheimer reiterated its Outperform rating and also boosted its price target to $132 from $115. Previously, Deutsche Bank upgraded its rating to Buy on February 18, 2025, and kept the price target unchanged to $120. On February 13, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $108 on the stock. Morgan Stanley upgraded its rating to a Overweight and increased its price target to $113 on January 10, 2025. Wolfe Research started tracking with a Outperform rating for this stock on November 15, 2024, and assigned it a price target of $110. In a note dated November 14, 2024, Citigroup initiated an Buy rating and provided a target price of $125 on this stock.
The stock price of Gilead Sciences, Inc [GILD] has been fluctuating between $62.07 and $119.96 over the past year. Currently, Wall Street analysts expect the stock to reach $109.43 within the next 12 months. Gilead Sciences, Inc [NASDAQ: GILD] shares were valued at $111.79 at the most recent close of the market. An investor can expect a potential drop of -2.11% based on the average GILD price forecast.
Analyzing the GILD fundamentals
The Gilead Sciences, Inc [NASDAQ:GILD] reported sales of 28.73B for trailing twelve months, representing a surge of 6.39%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 110.16 points at the first support level, and at 108.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 112.90, and for the 2nd resistance point, it is at 114.01.
Ratios To Look Out For
It’s worth pointing out that Gilead Sciences, Inc [NASDAQ:GILD]’s Current Ratio is 1.60. In addition, the Quick Ratio stands at 1.45 and the Cash Ratio stands at 0.83. Considering the valuation of this stock, the price to sales ratio is 4.85, the price to book ratio is 7.21 and price to earnings (TTM) ratio is 304.52.
Transactions by insiders
Recent insider trading involved Dickinson Andrew D, Chief Financial Officer, that happened on Mar 17 ’25 when 2500.0 shares were sold. Officer, ANDREW DICKINSON completed a deal on Mar 17 ’25 to buy 2500.0 shares. Meanwhile, Chief Financial Officer Dickinson Andrew D sold 17929.0 shares on Mar 10 ’25.
